Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43314 | 0.91 | SLC6A4 (0.46) | SLC6A4LDHACYP2A6TAAR1 | |
| SCHEMBL9484637 | 0.81 | AGXT (0.44) | AGXTIDO1SLC6A4PPARGPPARA | |
| SCHEMBL13006663 | 0.81 | SIGMAR1 (0.56) | SLC6A4CYP2A6TAAR1 | |
| SCHEMBL2555409 | 0.81 | SIGMAR1 (0.56) | SLC6A4CYP2A6TAAR1 | |
| SCHEMBL13189946 | 0.81 | SIGMAR1 (0.56) | SLC6A4CYP2A6TAAR1 | |
| SCHEMBL9694562 | 0.80 | TRPA1 (0.42) | SLC6A4LDHACYP1A2CYP2A6TAAR1 | |
| SCHEMBL14706798 | 0.80 | TSHR (0.42) | SLC6A4PPARGPPARALDHATAAR1 | |
| SCHEMBL12665322 | 0.80 | SLC6A4 (0.44) | SLC6A4CYP2A6TAAR1 | |
| SCHEMBL1840026 | 0.80 | TAAR1 (0.57) | TAAR1 | |
| SCHEMBL2551815 | 0.78 | PPARA (0.42) | AGXTIDO1PPARGPPARASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0908173-B1 | Use in perfumery of 1-methoxy-2-methyl-3-phenylpropane,1-(2-methoxypropyl)-4-methylbenzene and 3-methoxy-2,2,3,-trimethyl-1-phenylbutane | FIRMENICH & CIE (CH) | 2004-02-18 | — | — | EP | claimed |
| US-5939368-A | PERFUMES AND CHLORINATED COMPOUND FOR FLORAL SCENTS | FIRMENICH SA (CH) | 1999-08-17 | — | — | US | claimed |
| EP-0908173-A2 | Use in perfumery of 1-methoxy-2-methyl-3-phenylpropane,1-(2-methoxypropyl)-4-methylbenzene and 3-methoxy-2,2,3,-trimethyl-1-phenylbutane | FIRMENICH SA (CH) | 1999-04-14 | — | — | EP | claimed |
| EP-0352672-A2 | Process for the preparation of alkenyl aromatic compounds | BASF Aktiengesellschaft (DE) | 1990-01-31 | — | — | EP | claimed |
| JP-11199890-A | — | — | None | — | — | JP | disclosed |
| JP-11199890-A | — | — | None | — | — | JP | disclosed |
| EP-3274352-A1 | HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR | Bayer Pharma Aktiengesellschaft (DE) | 2018-01-31 | — | — | EP | disclosed |
| US-20170145029-A1 | CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF | Bayer Pharma AG (DE) | 2017-05-25 | — | — | US | disclosed |
| US-9604996-B2 | Cyclic thienouracil-carboxamides and use thereof | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-03-28 | — | — | US | disclosed |
| WO-2016150901-A1 | HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-09-29 | — | — | WO | disclosed |
| US-20160244461-A1 | CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-08-25 | — | — | US | disclosed |
| EP-0908173-B1 | Use in perfumery of 1-methoxy-2-methyl-3-phenylpropane,1-(2-methoxypropyl)-4-methylbenzene and 3-methoxy-2,2,3,-trimethyl-1-phenylbutane | FIRMENICH & CIE (CH) | 2004-02-18 | — | — | EP | disclosed |
| US-5939368-A | PERFUMES AND CHLORINATED COMPOUND FOR FLORAL SCENTS | FIRMENICH SA (CH) | 1999-08-17 | — | — | US | disclosed |
| US-5939368-A | PERFUMES AND CHLORINATED COMPOUND FOR FLORAL SCENTS | FIRMENICH SA (CH) | 1999-08-17 | — | — | US | disclosed |
| US-5939368-A | PERFUMES AND CHLORINATED COMPOUND FOR FLORAL SCENTS | FIRMENICH SA (CH) | 1999-08-17 | — | — | US | disclosed |
| JP-H11199890-A | USE OF 1-METHOXY-2-METHYL-3-PHENYLPROPANE, 1-(2-METHOXYPROPYL)-4-METHYLBENZENE AND 3-METHOXY-2,2,3-TRIMETHYL-1-PHENYLBUTANE IN PERFUME | FIRMENICH SA | 1999-07-27 | — | — | JP | disclosed |
| JP-H11199890-A | USE OF 1-METHOXY-2-METHYL-3-PHENYLPROPANE, 1-(2-METHOXYPROPYL)-4-METHYLBENZENE AND 3-METHOXY-2,2,3-TRIMETHYL-1-PHENYLBUTANE IN PERFUME | FIRMENICH SA | 1999-07-27 | — | — | JP | disclosed |
| EP-0908173-A2 | Use in perfumery of 1-methoxy-2-methyl-3-phenylpropane,1-(2-methoxypropyl)-4-methylbenzene and 3-methoxy-2,2,3,-trimethyl-1-phenylbutane | FIRMENICH SA (CH) | 1999-04-14 | — | — | EP | disclosed |
| EP-0908173-A2 | Use in perfumery of 1-methoxy-2-methyl-3-phenylpropane,1-(2-methoxypropyl)-4-methylbenzene and 3-methoxy-2,2,3,-trimethyl-1-phenylbutane | FIRMENICH SA (CH) | 1999-04-14 | — | — | EP | disclosed |
| EP-0908173-A2 | Use in perfumery of 1-methoxy-2-methyl-3-phenylpropane,1-(2-methoxypropyl)-4-methylbenzene and 3-methoxy-2,2,3,-trimethyl-1-phenylbutane | FIRMENICH SA (CH) | 1999-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160244461-A1 | CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF | TYMS, TPMT, PDF | AGXT 1087/4885IDO1 1650/4885SLC6A4 3331/4885 |
| US-20170145029-A1 | CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF | TYMS, TPMT, PDF | AGXT 1087/4885IDO1 1650/4885SLC6A4 3331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.